Treat Multiple Leukemia with Iclusig 15mg

An oral targeted cancer therapy containing ponatinib, a tyrosine kinase inhibitor. Doctors prescribe Iclusig 15mg  for Multiple Leukemia. Primarily used to treat adults with chronic myeloid leukemia [CML] or Philadelphia chromosome positive acute lymphoblastic leukemia [Ph+ALL] who cannot receive other kinase inhibitors or have the T315I mutation. To get more information on the medicine about its side effects ,mode of action do visit online at Globans Pharma website.